Chemistry in BRIC Countries

摘要

The R&D investment model of the Western Discovery Pharmaceutical Companies is starting to fall apart. The 7 emerging markets of Brazil, China, India, Mexico, Russia; South Korea and Turkey are estimated to have contributed, an unprecedented 51 percent of global pharmaceutical growth in 2009. The $ spent per ounce of innovation is said to make a dramatic difference when different R&D facilities are compared. This has had an impact on British and European R&D facilities.